Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Clinical Trials of topical JAK inhibitor Ruxolitinib cream met the primary endpoint in both pivotal phases 3 clinical trials with critical secondary endpoints, with a significantly higher proportion of the trial group achieving at least 75% improvement in the F-VASI score (a quantitative measure to assess skin symptoms in patients with vitiligo) relative to baseline than the placebo group at week 24 of treatment (118)
52 Atrial fibrillation (AF) is not only a complication of various cardiovascular diseases but also significantly increases the risk of cardiovascular events
Konoplev S, Jorgensen JL, Thomas DA, Lin E, Burger J, Kantarjian HM, Andreeff M , Medeiros LJ, Konopleva M
A alta concentrao ideal para maximizar os benefcios relacionados energia, ao metabolismo de gorduras e performance atltica
Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
